The shuttling of STAT5 was in fact cell type-specific, but the control coefficient had a higher value in CFU-E cells (S12 Fig), meaning that CFU-E cells would be particularly sensitive for inhibitors and npSTAT5 levels would decrease in the erythroid progenitor cells and not, as intended, in the lung cancer cells. This evidence concerns the gene STAT5B and lung cancer.